DE69218248D1 - Substituierte tetrahydroisochinolin-derivate und ihre anwendung in der therapie - Google Patents

Substituierte tetrahydroisochinolin-derivate und ihre anwendung in der therapie

Info

Publication number
DE69218248D1
DE69218248D1 DE69218248T DE69218248T DE69218248D1 DE 69218248 D1 DE69218248 D1 DE 69218248D1 DE 69218248 T DE69218248 T DE 69218248T DE 69218248 T DE69218248 T DE 69218248T DE 69218248 D1 DE69218248 D1 DE 69218248D1
Authority
DE
Germany
Prior art keywords
pct
tetrahydroisochinoline
therapy
derivatives
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69218248T
Other languages
English (en)
Other versions
DE69218248T2 (de
Inventor
Antonin Kozlik
Bruce Sargent
Patricia Needham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of DE69218248D1 publication Critical patent/DE69218248D1/de
Publication of DE69218248T2 publication Critical patent/DE69218248T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69218248T 1991-12-23 1992-12-12 Substituierte tetrahydroisochinolin-derivate und ihre anwendung in der therapie Expired - Fee Related DE69218248T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127306A GB9127306D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002900 WO1993013073A1 (en) 1991-12-23 1992-12-12 Substituted tetrahydroisoquinolines and their use as therapeutic agents
CN93109559A CN1045291C (zh) 1991-12-23 1993-06-26 制备被取代的四氢异喹啉化合物的方法

Publications (2)

Publication Number Publication Date
DE69218248D1 true DE69218248D1 (de) 1997-04-17
DE69218248T2 DE69218248T2 (de) 1997-06-19

Family

ID=36822306

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69218248T Expired - Fee Related DE69218248T2 (de) 1991-12-23 1992-12-12 Substituierte tetrahydroisochinolin-derivate und ihre anwendung in der therapie

Country Status (28)

Country Link
US (1) US5519034A (de)
EP (1) EP0618900B1 (de)
JP (1) JP2642244B2 (de)
CN (1) CN1045291C (de)
AT (1) ATE150015T1 (de)
AU (1) AU662584B2 (de)
BG (1) BG62326B1 (de)
CA (1) CA2126308A1 (de)
CZ (1) CZ282869B6 (de)
DE (1) DE69218248T2 (de)
DK (1) DK0618900T3 (de)
ES (1) ES2098721T3 (de)
FI (1) FI105401B (de)
GB (1) GB9127306D0 (de)
GR (1) GR3023568T3 (de)
HR (1) HRP921458B1 (de)
HU (2) HUT70495A (de)
IL (1) IL104170A (de)
IN (1) IN174437B (de)
MX (1) MX9207495A (de)
NO (1) NO301474B1 (de)
NZ (1) NZ246155A (de)
PL (1) PL173944B1 (de)
RO (1) RO114790B1 (de)
RU (1) RU2122999C1 (de)
SI (1) SI9200410B (de)
SK (1) SK280318B6 (de)
WO (1) WO1993013073A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ290661B6 (cs) * 1993-06-22 2002-09-11 Knoll Aktiengesellschaft Tetrahydroisochinolinová sloučenina, způsob její přípravy, farmaceutický prostředek s jejím obsahem a použití
US5389638A (en) * 1993-09-10 1995-02-14 Abbott Laboratories Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
MX9709914A (es) * 1995-06-07 1998-03-31 Pfizer Derivados de acido bifenil-2-carboxilico-tetrahidro-isoquinolin-6-ilo, su preparacion y el uso de los mismos.
GB9524681D0 (en) * 1995-12-02 1996-01-31 Knoll Ag Chemical process
JP2000507569A (ja) * 1996-03-29 2000-06-20 日本ワイスレダリー株式会社 抗精神病薬ならびに鎮痛薬を製造するための、1,1―ジアルキル―1,2,3,4―テトラヒドロイソキノリンの使用
EP1023269A4 (de) * 1997-09-30 2001-06-27 Molecular Design Int Beta3-adrenoreceptor-agonisten, agonist-zubereitungen und verfahren zu ihrer verwendung
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
US5919794A (en) * 1998-05-11 1999-07-06 Virginia Commonwealth University Methods of using pharmaceutical tetrahydroisoquinolines
GB0012214D0 (en) * 2000-05-19 2000-07-12 Merck Sharp & Dohme Therapeutic agents
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
WO2003007959A1 (en) * 2001-07-16 2003-01-30 Fujisawa Pharmaceutical Co., Ltd. Quinoxaline derivatives which have parp inhibitory action
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
ES2239196T3 (es) * 2002-12-02 2005-09-16 Schwarz Pharma Ag Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
ATE450513T1 (de) * 2004-11-04 2009-12-15 Mallinckrodt Inc Opiatzwischenprodukte und syntheseverfahren
US7511060B2 (en) 2005-10-21 2009-03-31 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
US7622586B2 (en) * 2005-10-21 2009-11-24 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
CN102083797B (zh) * 2008-04-01 2014-06-04 Abbvie公司 四氢异喹啉、含有它们的药物组合物和它们在治疗中的用途
US20090312558A1 (en) * 2008-06-13 2009-12-17 Reliance Life Sciences Pvt. Ltd. Process for the preparation of arylcyclopropoane carboxylic carbonitriles, and compounds derived therefrom
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
JP2014521682A (ja) 2011-08-05 2014-08-28 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー アミノクロマン、アミノチオクロマンおよびアミノ−1,2,3,4−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用
WO2013072520A1 (en) 2011-11-18 2013-05-23 AbbVie Deutschland GmbH & Co. KG N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
LT2872145T (lt) 2012-07-12 2022-06-27 Emalex Biosciences, Inc. Sujungti benzazepinai tureto sindromui gydyti
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
KR101802048B1 (ko) * 2013-04-02 2017-12-28 안지 파마슈티컬 코퍼레이션 리미티드 항신경퇴행성제로서의 다작용성 퀴놀린 유도체
CN103435545B (zh) * 2013-08-14 2015-10-07 中国药科大学 四氢异喹啉季铵盐类衍生物、其制备方法及其镇痛用途
EP3057958B1 (de) 2013-10-17 2019-05-01 AbbVie Deutschland GmbH & Co. KG Aminotetralin- und aminoindanderivate, pharmazeutische zusammensetzungen damit und deren verwendung in der therapie
CA2924689A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
PL3057595T3 (pl) 2013-10-18 2021-03-08 Emalex Biosciences, Inc. Skondensowane benzazepiny do leczenia jąkania
WO2019099294A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
AR113878A1 (es) 2017-11-14 2020-06-24 Merck Sharp & Dohme Compuestos de biarilo sustituido como inhibidores de indolamina 2,3-dioxigenasa (ido)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR868733A (fr) * 1939-10-14 1942-01-14 Troponwerke Dinklage & Co Procédé pour la fabrication des composés d'isoquinoleine
US3717639A (en) * 1967-05-04 1973-02-20 Little Inc A Process for the preparation of 1-(2-nitro-3,4-di-lower-alkoxybenzyl)isoquinolines
US3755330A (en) * 1967-08-25 1973-08-28 Sandoz Ag 1-{60 -hydroxybenzyl 3-methyl, 1,2,3,4-tetrahydroiso quinolino-2-carbonitriles
JPS4933805B1 (de) * 1969-01-31 1974-09-10
US3852448A (en) * 1971-02-04 1974-12-03 Sandoz Ag N-substituted amino-n-nitroso-aminoacetonitriles for treating hypertension
US3872130A (en) * 1971-09-27 1975-03-18 Mead Johnson & Co 1-hydroxyisoquinolones
US3777026A (en) * 1972-06-14 1973-12-04 Sandoz Ag N-substituted amino-n-nitroso-amino-acetonitriles as anti-anginal agents
US4013664A (en) * 1973-06-20 1977-03-22 Research Corporation Synthesis of hernandaline
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
US4126615A (en) * 1975-12-12 1978-11-21 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt Process for the manufacture of pure isoquinoline derivatives
US4194044A (en) * 1976-12-06 1980-03-18 Hoffmann-La Roche Inc. Process for preparing 3-phenoxy morphinans
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
US4514569A (en) * 1982-01-28 1985-04-30 Hendrickson James B Synthesis of 1-substituted isoquinolines
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
DK8386A (da) * 1986-01-15 1987-07-09 Tpo Pharmachim Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
US4737504A (en) * 1986-07-25 1988-04-12 Ohio State University Research Foundation 5-fluoro-and 8-fluoro-trimetoquinol compounds and the processes for their preparation
US4915879A (en) * 1986-09-19 1990-04-10 Automatic Liquid Packaging, Inc. Signal coupling for humidifier container
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein

Also Published As

Publication number Publication date
AU3158693A (en) 1993-07-28
HRP921458A2 (en) 1995-06-30
DE69218248T2 (de) 1997-06-19
GR3023568T3 (en) 1997-08-29
HRP921458B1 (en) 1999-02-28
JPH07502279A (ja) 1995-03-09
RU2122999C1 (ru) 1998-12-10
NZ246155A (en) 1996-02-27
BG98822A (bg) 1995-05-31
SI9200410A (en) 1993-09-30
NO301474B1 (no) 1997-11-03
GB9127306D0 (en) 1992-02-19
ES2098721T3 (es) 1997-05-01
SI9200410B (sl) 2002-02-28
CZ282869B6 (cs) 1997-11-12
SK75194A3 (en) 1995-08-09
CN1045291C (zh) 1999-09-29
WO1993013073A1 (en) 1993-07-08
SK280318B6 (sk) 1999-11-08
DK0618900T3 (da) 1997-04-07
IL104170A (en) 1999-04-11
MX9207495A (es) 1993-07-01
EP0618900B1 (de) 1997-03-12
IL104170A0 (en) 1993-05-13
BG62326B1 (bg) 1999-08-31
US5519034A (en) 1996-05-21
IN174437B (de) 1994-12-03
HUT70495A (en) 1995-10-30
JP2642244B2 (ja) 1997-08-20
AU662584B2 (en) 1995-09-07
RU94030499A (ru) 1996-04-20
NO942375L (no) 1994-06-22
FI943018A (fi) 1994-06-22
FI943018A0 (fi) 1994-06-22
HU9401878D0 (en) 1994-09-28
CA2126308A1 (en) 1993-07-08
HU211302A9 (en) 1995-11-28
CZ153494A3 (en) 1995-07-12
ATE150015T1 (de) 1997-03-15
PL173944B1 (pl) 1998-05-29
RO114790B1 (ro) 1999-07-30
CN1096780A (zh) 1994-12-28
NO942375D0 (de) 1994-06-22
EP0618900A1 (de) 1994-10-12
FI105401B (fi) 2000-08-15

Similar Documents

Publication Publication Date Title
DE69218248D1 (de) Substituierte tetrahydroisochinolin-derivate und ihre anwendung in der therapie
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
FI934983A (fi) Kinuklidinderivat foer behandling av inflammatoriska och gastrointestinala sjukdomar
MY132705A (en) Novel compounds with analgesic effect
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE69532415D1 (de) Schmelzextrudierte oral verabreichbare opioidformulierungen
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
ATE219073T1 (de) Benzopyran derivate mit leukotrien- antagonistischer wirkung
ATE201677T1 (de) 4-imidomethyl-1-(2'-phenyl-2-oxoethyl)-piperidi e als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung
LV11899A (lv) Jauni adenozina atvasinajumi to iegusanas panemiens
SE9402880D0 (sv) New peptide derivatives
PT986386E (pt) Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
FI970434A (fi) Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
NO950177D0 (no) Farmakologisk aktive erivater
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
HU9502647D0 (en) Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs
TH18788A (th) การรวมกันแบบใหม่ของสารสกัดกั้นหน่วยรับบีตาและยาชาแบบเฉพาะที่
UA32423C2 (uk) Тетрагідроізохінолінові сполуки, які мають антагоністичну активність у відношенні до допамінових рецепторів d1 і d2, спосіб їх одержання, фармацевтична композиція на їх основі і спосіб зв'язування допамінових рецепторів d1 і d2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee